益方生物-U
(688382)
| 流通市值：116.13亿 | | | 总市值：116.13亿 |
| 流通股本：5.78亿 | | | 总股本：5.78亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 42,542,363.91 | 37,289,660.96 | 30,893,466.9 | 19,163,847.37 |
| 营业收入 | 42,542,363.91 | 37,289,660.96 | 30,893,466.9 | 19,163,847.37 |
| 二、营业总成本 | 85,655,003.18 | 353,562,227.75 | 205,986,997.9 | 131,684,739.5 |
| 营业成本 | 1,628,552.45 | 5,018,016.83 | 4,070,771.63 | 2,486,836.43 |
| 税金及附加 | 36,207.15 | 113,621.96 | 82,920.86 | 58,725.22 |
| 管理费用 | 8,026,051.79 | 45,256,666.54 | 32,528,946.33 | 22,048,832.54 |
| 研发费用 | 80,394,210.56 | 325,792,456.15 | 189,649,512.55 | 115,458,842.89 |
| 财务费用 | -4,430,018.77 | -22,618,533.73 | -20,345,153.47 | -8,368,497.58 |
| 其中:利息费用 | 185,182.92 | 835,121.69 | - | - |
| 其中:利息收入 | -4,939,043.38 | 24,985,601.94 | -21,653,189.72 | -9,163,267.67 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 719,697.98 | 2,488,403.42 | 1,445,446.01 | 886,746.71 |
| 加:投资收益 | - | 901,325.59 | 477,989.71 | 84,099.81 |
| 信用减值损失(新) | -2,230,907 | -12,565,921.02 | -16,693,284.09 | -16,499,814.5 |
| 其他收益 | 364,586.08 | 8,825,484.12 | 8,617,380.26 | 8,617,380.26 |
| 四、营业利润 | -44,259,262.21 | -316,623,274.68 | -181,245,999.11 | -119,432,479.85 |
| 减:营业外支出 | - | 3,000 | - | - |
| 五、利润总额 | -44,259,262.21 | -316,626,274.68 | -181,245,999.11 | -119,432,479.85 |
| 减:所得税费用 | 107,954.7 | 239,526 | 139,153.2 | - |
| 六、净利润 | -44,367,216.91 | -316,865,800.68 | -181,385,152.31 | -119,432,479.85 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -44,367,216.91 | -316,865,800.68 | -181,385,152.31 | -119,432,479.85 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -44,367,216.91 | -316,865,800.68 | -181,385,152.31 | -119,432,479.85 |
| 扣除非经常损益后的净利润 | -45,451,500.97 | -328,838,487.81 | -191,925,968.29 | -129,020,706.63 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.08 | -0.55 | -0.31 | -0.21 |
| (二)稀释每股收益 | -0.08 | -0.55 | -0.31 | -0.21 |
| 八、其他综合收益 | -1,203,735.61 | -506,075.02 | -559,520.77 | -463,965.38 |
| 归属于母公司股东的其他综合收益 | -1,203,735.61 | -506,075.02 | -559,520.77 | -463,965.38 |
| 九、综合收益总额 | -45,570,952.52 | -317,371,875.7 | -181,944,673.08 | -119,896,445.23 |
| 归属于母公司股东的综合收益总额 | -45,570,952.52 | -317,371,875.7 | -181,944,673.08 | -119,896,445.23 |
| 公告日期 | 2026-04-29 | 2026-04-15 | 2025-10-30 | 2025-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |